FOXO1 and polycystic ovary syndrome: The metabolic improvements provided by microbiota, as shown by Xiong et al., together with the FOXO1-mediated anti-apoptotic effects observed by Sun et al., jointly confirm therapeutic benefits in PCOS biology [34].